Le Lézard
Classified in: Business
Subjects: MAV, FOR, CFG

Media Advisory - Prime Minister's itinerary for Tuesday, January 31, 2023


OTTAWA, ON, Jan. 30, 2023 /CNW/ -

Note: All times local

National Capital Region, Canada


Private meetings


10:00 a.m.

The Prime Minister will chair the Cabinet meeting.



7:15 p.m. 

The Prime Minister will deliver remarks at a Lunar New Year reception. He will be joined by the Minister of International Trade, Export Promotion, Small Business and Economic Development, Mary Ng.




Notes for media:


  • Open coverage
  • Media wishing to cover the event must be accredited with the Parliamentary Press Gallery.
  • Media interested in participating can contact media@pmo-cpm.gc.ca for details.

The Prime Minister will speak with the President of Ukraine, Volodymyr Zelenskyy.

 

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 03:49
This morning, Strauss Group announced its financial results for the full...

at 03:34
Riding on some $20 billion in investment pledges announced during 2022 by leading companies such as Foxconn Technology, BYD Co., and Amazon Web Services, Thailand started implementing in January 2023 an even more ambitious five-year investment...

at 03:30
OneThird, an AI-powered food tech company created to address the annual loss of one-third of all food produced due to spoilage, today announced the company has raised $3M (2.75M euros) in a late-seed funding...

at 03:14
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY...

at 03:10
Protect Environmental, an industry leader in the measurement, mitigation, and monitoring of environmental carcinogens, today announced a consumer finance partnership with GreenSky®, a Goldman Sachs Company, to offer families protection and peace of...

at 02:35
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic...



News published on 30 january 2023 at 20:04 and distributed by: